Ingredients may include glycopyrrolate (anticholinergic), aluminum chloride (astringent), and glutaraldehyde (protein coagulant) to control localized sweating
Given the increasing availability of CV safety outcomes data for glucose-lowering medications, it has become apparent that certain agents within the GLP-1RA and SGLT-2 inhibitor classes reduce the risk of CV events in those with high-risk CV or CKD [16,17,18,19,20,21]
Probably, especially for higher-risk groups
SPECIFICATIONS Disclaimer: Please note that the product images displayed on our website may sometimes differ from the actual packaging
Unlike other diabetes complications, the incidence of renal failure due to CKD has not decreased over the years and even increased in low to middle-income countries [3]